# Bupivacaine in the Treatment of Postoperative Pain of Impacted Third Molar Extraction

> **NCT03950700** · PHASE4 · COMPLETED · sponsor: **CES University** · enrollment: 40 (actual)

## Conditions studied

- Teeth, Impacted

## Interventions

- **DRUG:** Bupivacaine-epinephrine
- **DRUG:** Saline Solution

## Key facts

- **NCT ID:** NCT03950700
- **Lead sponsor:** CES University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-01-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03950700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03950700, "Bupivacaine in the Treatment of Postoperative Pain of Impacted Third Molar Extraction". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03950700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*